Sinensetin serves as an AMPK activator to inhibit RANKL-induced osteoclastogenesis via osteoclast cytoskeleton reorganization

Abstract Osteoporosis is a skeletal condition caused by an excess of osteoclasts, resulting in an imbalance in bone metabolism. Sinensetin (SIN), one of the main ingredients in citrus fruits, provides a variety of pharmacological properties, like antioxidant, but its effects on osteoporosis remains...

Description complète

Détails bibliographiques

Auteurs principaux:	Yijie Gao, Rui Zhou, Xixi Lin, Zhijuan Liu, Yuangang Su, Haoyu Lian, Bin Lin, Xiaofei Ding, Shijie Liao, Xiangde Li, Jinmin Zhao, Jiake Xu, Ren Xu, Qian Liu, Fangming Song
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2025-07-01
Collection:	Journal of Translational Medicine
Sujets:	Osteoclast AMPK Cytoskeleton reorganization ROS Sinensetin
Accès en ligne:	https://doi.org/10.1186/s12967-025-06708-8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!